Physician profile
Robert J Murphy
NPI 1831453166
$993.77
in general payments reported to CMS, 2019-2025
24 companies · $184 in 2025
The $184 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $112 · 2022: $136 · 2023: $216 · 2024: $346 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $718 · Education: $28.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $717.52 |
| Education | $28.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $115.35 | 2021-2024 | Vyepti |
| Teva Pharmaceuticals USA, INC. | $95.63 | 2024 | Austedo Xr |
| Tanabe Pharma America, INC. | $90.62 | 2023-2025 | Radicava |
| Argenx US, INC. | $67.38 | 2022-2023 | Vyvgart |
| Ucb, INC. | $65.39 | 2021-2024 | Rystiggo |
| Novartis Pharmaceuticals Corporation | $55.54 | 2024 | |
| Globus Medical, INC. | $54.69 | 2025 | Senza |
| Eisai INC. | $49.95 | 2023 | |
| Abbvie INC. | $44.51 | 2021-2024 | |
| Microtransponder, INC. | $42.61 | 2025 | |
| Tg Therapeutics, INC. | $38.09 | 2024 | |
| Merz Pharmaceuticals, LLC | $33.63 | 2025 | Xeomin |
| Biogen, INC. | $32.08 | 2021-2024 | Skyclarys |
| Amylyx Pharmaceuticals, INC. | $30.86 | 2023-2024 | Relyvrio |
| Janssen Biotech, INC. | $29.35 | 2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $21.72 | 2021 | |
| Celgene Corporation | $21.40 | 2022 | |
| Nevro Corp. | $19.95 | 2022 | |
| Genentech USA, INC. | $19.54 | 2024 | Ocrevus Zunovo, Ocrevus |
| Kyowa Kirin, INC. | $18.55 | 2023 | Nourianz |
| Horizon Therapeutics Plc | $18.04 | 2022 | |
| Siemens Medical Solutions USA, INC. | $16.17 | 2023 | Magnetom Altea |
| Ge Healthcare | $12.72 | 2023 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.